The Korean Journal of Physiology and Pharmacology

The Korean Society of Pharmacology (대한약리학회)
권호 표지

Effect of PUVA on Nerve Growth Factor Expression in Cultured Keratinocytes

  • Lee, Mu-Hyoung (Departments of Dermatology, College of Medicine, Kyunghee University) ;
  • Kim, Hwi-Jun (Departments of Dermatology, College of Medicine, Kyunghee University) ;
  • Lee, Jin-Woo (Departments of Immunology Research Laboratory, College of Medicine, Kyunghee University) ;
  • Kim, Young-Il (Departments of Immunology Research Laboratory, College of Medicine, Kyunghee University)
  • Published : 2002.10.21
Download PDF
⟨ Previous Next ⟩

Abstract

Nerve growth factor (NGF) is an important autocrine growth factor and also a survival factor for keratinocytes. NGF may act in the hyperproliferative condition, psoriasis. Clinically, the combination of psoralen and UVA (PUVA) has been used in the treatment of a wide variety of cutaneous disorders, such as psoriasis and vitiligo. However, the precise therapeutic mechanism of PUVA on the dermatologic diseases remains unclear. The purpose of this study was to examine whether the expression of NGF in cultured keratinocytes is influenced by PUVA. Thus, normal human keratinocytes were isolated from neonatal foreskin, and the third to fifth-passaged cells were used in this study. The cells were exposed to various doses of UVA (30, 60, 120 $mJ/cm^2)$ after adding 8-methoxypsoralen (8-MOP) to examine the expression of NGF mRNA. The RNA and protein of the cells were extracted at various time points (1, 8, 24 hours) after UVA irradiation to examine the expression of NGF mRNA and production of NGF protein. In keratinocytes, there were no differences in the expression of NGF mRNA between the different doses of UVA irradiation, however, the expression of NGF mRNA in UVA and PUVA groups tended to increase as the time increased. The expression of NGF mRNA was the highest in PUVA group, followed by UVA group and the lowest in 8-MOP group. The expressions of NGF protein at 1 and 8 hours after UVA irradiation were lower in the PUVA group than in the other groups. This study showed that the expression level of NGF protein in keratinocytes was relatively lower in the PUVA groups than in the other groups, suggesting that the therapeutic mechanism of PUVA in psoriasis is related to the decrease of NGF protein.

Keywords

References

  1. Aloe L, Levi-Montalcini R. Mast cells increase in tissues of neonatal rats injected with the nerve growth factor. Brain Res 133: 358－ 366, 1977 https://doi.org/10.1016/0006-8993(77)90772-7
  2. Armagni C, Di Francesco C, Schaltegger H. Electron microscopy studies on dermal nerves in psoriasis. Acta Derm Venereol (Suppl) (Stockh) 87: 68－70, 1979
  3. Bischoff SC, Dahinden CA. Effect of nerve growth factor on the release of inflammatory mediators by mature human basophils. Blood 79: 2662－2669, 1992
  4. Di Marco E, Marchisio PC, Bondanza S, Franzi AT, Cancedda R, De Luca M. Growth-regulated synthesis and secretion of biologically active nerve growth factor by human keratinocytes. J Biol Chem 266: 21718－21722, 1991
  5. Di Marco E, Mathor M, Bondanza S, Cutuli N, Marchisio PC, Cancedda R, De Luca M. Nerve growth factor binds to normal human keratinocytes through high and low affinity receptors and stimulates their growth by a novel autocrine loop. J Biol Chem 268: 22838－22846, 1993
  6. Donnerer J, Schuligoi R, Stein C. Increased content and transport of substance P and calcitoningene-related peptide in sensory nerves innervating inflamed tissue: evidence for a regulatory function of nerve growth factor in vivo. Neuroscience 49: 693－ 698, 1992 https://doi.org/10.1016/0306-4522(92)90237-V
  7. Donnerer J, Schuligoi R, Stein C, Amann R. Upregulation, release and axonal transport of substance P and calcitonin gene-related peptide in adjuvant inflammation and regulatory function of nerve growth factor. Regul Pept 46: 150－154, 1993
  8. Fantini F, Magnoni C, Bracci-Laudiero L, Pincelli C. Nerve growth factor is increased in psoriatic skin. J Invest Dermatol 105: 854－ 855, 1995 https://doi.org/10.1111/1523-1747.ep12326689
  9. Gillardon F, Eschenfelder C, Rush RA, Zimmerman M. Increase in neuronal Jun immunoreactivity and epidermal NGF levels following UV exposure of rat skin. Neuroreport 6: 1322－1324, 1995 https://doi.org/10.1097/00001756-199506090-00023
  10. Goldsmith LA. Toads and Psoriasis. Arch Dermatol 122: 939－940, 1986 https://doi.org/10.1001/archderm.122.8.939
  11. Haegerstrand A, Jonzon B, Dalsgaard CJ, Nilsson J. Vasoactive intestinal polypeptide stimulates cell proliferation and adenyl cyclase activity of cultured human keratinocytes. Proc Natl Acad Sci USA 86: 5993－5996, 1989 https://doi.org/10.1073/pnas.86.15.5993
  12. Krueger JG, Wolfe JT, Nabeya RT, Vallat VP, Gilleaudeau P, Heftler NS, Austin LM, Gottlieb AB. Successful ultraviolet B treatment of psoriasis is accompanied by a reversal of keratinocyte pathology and by selective depletion of intraepidermal T cells. J Exp Med 182: 2057－2068, 1995 https://doi.org/10.1084/jem.182.6.2057
  13. Levi-Montalcini R. The nerve growth factor 35 years later. Science 237: 1154－1162, 1987 https://doi.org/10.1126/science.3306916
  14. Li AKC, Koroly MJ, Schattenkerk ME, Malt RA, Young M. Nerve growth factor: acceleration of the rate of wound healing in mice. Proc Natl Acad Sci USA 77: 4379－4381. 1980 https://doi.org/10.1073/pnas.77.7.4379
  15. Lindsay R, Harmar A. Nerve growth factor regulates expression of neuropeptide genes in adult sensory neurons. Nature 337: 362 －364, 1989 https://doi.org/10.1038/337362a0
  16. Marconi A, Vaschieri C, Zanoli S, Giannetti A, Pincelli C. Nerve growth factor protects human keratinocytes from ultraviolet- B-induced apoptosis. J Invest Dermatol 113: 920－927, 1999 https://doi.org/10.1046/j.1523-1747.1999.00773.x
  17. Otten U, Ehrhard P, Peck R. Nerve growth factor induces growth and differentiation of human B lymphocytes. Proc Natl Acad Sci USA 86: 10059－10063, 1989 https://doi.org/10.1073/pnas.86.24.10059
  18. Pathak MA et al. Photobiology and photochemistry of furocoumarins (psoralens). In: Pathak MA, et al. ed, Sunlight and Man: Normal and Abnormal Photobiologic Responses. Tokyo University Press, Tokyo, p 25, 1974
  19. Pearce FL, Thompson HL. Some characteristics of histamine secretion from rat peritoneal mast cells stimulated with nerve growth factor. J Physiol 372: 379－393, 1986 https://doi.org/10.1113/jphysiol.1986.sp016014
  20. Pincelli C. Neuropeptides and Psoriasis. In: Roenigk Jr. HH, Maibach HI ed, Psoriasis. Marcel Dekker Inc., New York, p 393 －397, 1998
  21. Pincelli C, Fantini F, Giannetti A. Neuropeptides and skin inflammation. Dermatology 187: 153－158, 1993
  22. Pincelli C, Fantini F, Giannetti A. Nerve growth factor and the skin. Int J Dermatol 33: 308－312, 1994 https://doi.org/10.1111/j.1365-4362.1994.tb01058.x
  23. Pincelli C, Fantini F, Romualdi P, Sevignani C, Lesa G, Benassi L, Giannetti A. Substance P is diminished and vasoactive intestinal peptide is augmented in psoriatic lesions and these peptides exert disparate effects on the proliferation of cultured human keratinocytes. J Invest Dermatol 98: 421－427, 1992 https://doi.org/10.1111/1523-1747.ep12499846
  24. Pincelli C, Sevignani C, Manfredini R, Grande A, Fantini F, Bracci-Laudiero L. Expression and function of nerve growth factor and nerve growth factor receptor on cultured keratinocytes. J Invest Dermatol 103: 13－18, 1994 https://doi.org/10.1111/1523-1747.ep12388914
  25. Pohl J, Christophers E. Photoinactivation of skin fibroblasts by fractionated treatment with 8-methoxypsoralen and UVA. J Invest Dermatol 73: 176－179, 1979 https://doi.org/10.1111/1523-1747.ep12581643
  26. Raychaudhuri SP, Jiang WY, Farber EM. Psoriatic keratinocytes express high levels of nerve growth factor. Acta Derm Venereol 78: 84－86, 1998 https://doi.org/10.1080/000155598433368
  27. Saade NE, Nasr IW, Massaad CA, Safieh-Garabedian B, Jabbur SJ, Kanaan SA. Modulation of ultraviolet-induced hyperalgesia and cytokine upregulation by interleukins 10 and 13. Br J Pharmacol 131: 1317－1324, 2000. https://doi.org/10.1038/sj.bjp.0703699
  28. Thorpe LW, Werrbach-Perez K, Perez-Polo JR. Effects of nerve growth factor on the expression of interleukin-2 receptors on cultured human lymphocytes. Ann N Y Acad Sci 496: 310－311, 1987 https://doi.org/10.1111/j.1749-6632.1987.tb35781.x
  29. Tron VA, Coughlin MD, Jang DE, Stanisz J, Sauder DN. Expression and modulation of nerve growth factor in murine keratinocytes (PAM 212). J Clin Invest 85: 1085－1089, 1990 https://doi.org/10.1172/JCI114539
  30. Weddel G, Cowan MA, Palmer E, Ramaswamy S. Psoriatic skin. Arch Dermatol 91: 252－266, 1965 https://doi.org/10.1001/archderm.1965.01600090060012
  31. Wrone-Smith T, Johnson T, Nelson B, Boise LH, Thompson CB, Nunez G, Nickoloff BJ. Discordant expression of bcl-x and bcl-2 by keratinocytes in vitro and psoriatic keratinocytes in vivo. Am J Pathol 146: 1079－1088, 1995
  32. Wrone-Smith T, Mitra RS, Thompson CB, Jasty R, Castle VP, Nickoloff BJ. Keratinocytes derived from psoriatic plaques are resistant to apoptosis compared with normal skin. Am J Pathol 151: 1321－1329, 1997
  33. Vallat VP, Gilleaudeau P, Battat L, Wolfe J, Nabeya R, Heftler N, Hodak E, Gottlieb AB, Krueger JG. PUVA bath therapy strongly suppresses immunological and epidermal activation in psoriasis: a possible cellular basis for remittive therapy. J Exp Med 180: 283－296, 1994 https://doi.org/10.1084/jem.180.1.283
  34. Yaar M, Grossman K, Eller M, Gilchrest B. Evidence for nerve growth factor-mediated paracrine effects in human epidermis. J Cell Biol 115: 821－828, 1991 https://doi.org/10.1083/jcb.115.3.821